Yahoo! Finance: Biotechnology Industry News: Sobi gains rights to distribute RAVICTI® on a named patient use basis in Middle East from Hyperion Therapeutics, Inc.

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Want new traffic sources? Download a copy of our complimentary eBook today, and read about sources that most marketers are not aware of. From our sponsors

Sobi gains rights to distribute RAVICTI® on a named patient use basis in Middle East from Hyperion Therapeutics, Inc. Oct 1st 2013, 06:04 [Thomson Reuters ONE] - Stockholm, Sweden and South San Francisco, CA -- October 1, 2013 -- Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) and Hyperion Therapeutics, Inc., (NASDAQ: HPTX) announced today that Sobi has been ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions